BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35936656)

  • 21. Clinical variability of the systemic juvenile idiopathic arthritis course: literature review based on case series.
    Boyarchuk O; Kovalchuk T; Kovalchuk N; Chubata O
    Reumatologia; 2020; 58(6):436-443. PubMed ID: 33456087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus: A Systematic Review of the Diagnostic Aspects.
    Abdirakhmanova A; Sazonov V; Mukusheva Z; Assylbekova M; Abdukhakimova D; Poddighe D
    Front Med (Lausanne); 2021; 8():681875. PubMed ID: 34150813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
    Put K; Avau A; Brisse E; Mitera T; Put S; Proost P; Bader-Meunier B; Westhovens R; Van den Eynde BJ; Orabona C; Fallarino F; De Somer L; Tousseyn T; Quartier P; Wouters C; Matthys P
    Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
    Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
    Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Davì S; Minoia F; Pistorio A; Horne A; Consolaro A; Rosina S; Bovis F; Cimaz R; Gamir ML; Ilowite NT; Kone-Paut I; Feitosa de Oliveira SK; McCurdy D; Silva CA; Sztajnbok F; Tsitsami E; Unsal E; Weiss JE; Wulffraat N; Abinun M; Aggarwal A; Apaz MT; Astigarraga I; Corona F; Cuttica R; D'Angelo G; Eisenstein EM; Hashad S; Lepore L; Mulaosmanovic V; Nielsen S; Prahalad S; Rigante D; Stanevicha V; Sterba G; Susic G; Takei S; Trauzeddel R; Zletni M; Ruperto N; Martini A; Cron RQ; Ravelli A;
    Arthritis Rheumatol; 2014 Oct; 66(10):2871-80. PubMed ID: 25044674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic juvenile idiopathic arthritis-associated lung disease: A retrospective cohort study.
    Belozerov KE; Solomatina NM; Isupova EA; Kuznetsova AA; Kostik MM
    World J Clin Pediatr; 2024 Mar; 13(1):88912. PubMed ID: 38596441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis.
    Behrens EM; Beukelman T; Paessler M; Cron RQ
    J Rheumatol; 2007 May; 34(5):1133-8. PubMed ID: 17343315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
    Ravelli A; Minoia F; Davì S; Horne A; Bovis F; Pistorio A; Aricò M; Avcin T; Behrens EM; De Benedetti F; Filipovic L; Grom AA; Henter JI; Ilowite NT; Jordan MB; Khubchandani R; Kitoh T; Lehmberg K; Lovell DJ; Miettunen P; Nichols KE; Ozen S; Pachlopnik Schmid J; Ramanan AV; Russo R; Schneider R; Sterba G; Uziel Y; Wallace C; Wouters C; Wulffraat N; Demirkaya E; Brunner HI; Martini A; Ruperto N; Cron RQ; ; ; ;
    Ann Rheum Dis; 2016 Mar; 75(3):481-9. PubMed ID: 26865703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperferritinemia in Hemophagocytic Lymphohistiocytosis: A Single Institution Experience in Pediatric Patients.
    Basu S; Maji B; Barman S; Ghosh A
    Indian J Clin Biochem; 2018 Jan; 33(1):108-112. PubMed ID: 29371779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
    Ravelli A; Minoia F; Davì S; Horne A; Bovis F; Pistorio A; Aricò M; Avcin T; Behrens EM; De Benedetti F; Filipovic L; Grom AA; Henter JI; Ilowite NT; Jordan MB; Khubchandani R; Kitoh T; Lehmberg K; Lovell DJ; Miettunen P; Nichols KE; Ozen S; Pachlopnik Schmid J; Ramanan AV; Russo R; Schneider R; Sterba G; Uziel Y; Wallace C; Wouters C; Wulffraat N; Demirkaya E; Brunner HI; Martini A; Ruperto N; Cron RQ; ; ; ;
    Arthritis Rheumatol; 2016 Mar; 68(3):566-76. PubMed ID: 26314788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of Cytokine Storm Syndrome Scoring Systems in Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children.
    Reiff DD; Cron RQ
    ACR Open Rheumatol; 2021 Dec; 3(12):820-826. PubMed ID: 34431626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic onset juvenile idiopathic arthritis: a single center experience.
    Sağ E; Uzunoğlu B; Bal F; Sönmez HE; Demir S; Bilginer Y; Özen S
    Turk J Pediatr; 2019; 61(6):852-858. PubMed ID: 32134578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or -6 therapy.
    Ulu K; Aliyev E; Kılıç Könte E; Tanatar A; Türkmen Ş; Doğantan Ş; Kızıldağ Z; Kasap Demir B; Gezgin Yıldırım D; Otar Yener G; Öztürk K; Baba Ö; Açarı C; Kılbaş G; Taşkın SN; Haşlak F; Çağlayan Ş; Bağlan E; Dundar HA; Başaran Ö; Barut K; Karadağ ŞG; Coşkuner T; Sönmez HE; Yüksel S; Kalyoncu M; Bakkaloğlu SA; Ünsal E; Paç Kısaarslan A; Bilginer Y; Aktay Ayaz N; Kasapçopur Ö; Özen S; Sözeri B
    Rheumatology (Oxford); 2024 Mar; ():. PubMed ID: 38441301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Ravelli A; Minoia F; Davì S; Horne A; Bovis F; Pistorio A; Aricò M; Avcin T; Behrens EM; De Benedetti F; Filipovic A; Grom AA; Henter JI; Ilowite NT; Jordan MB; Khubchandani R; Kitoh T; Lehmberg K; Lovell DJ; Miettunen P; Nichols KE; Ozen S; Pachlopnik Schmid J; Ramanan AV; Russo R; Schneider R; Sterba G; Uziel Y; Wallace C; Wouters C; Wulffraat N; Demirkaya E; Brunner HI; Martini A; Ruperto N; Cron RQ
    RMD Open; 2016; 2(1):e000161. PubMed ID: 26848401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.
    Krei JM; Møller HJ; Larsen JB
    Clin Exp Immunol; 2021 Feb; 203(2):174-182. PubMed ID: 33128796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.
    Wafa A; Hicham H; Naoufal R; Hajar K; Rachid R; Souad B; Mouna M; Zoubida MT; Mohamed A
    Clin Rheumatol; 2022 Jul; 41(7):2021-2033. PubMed ID: 35179662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
    Arduini A; Marasco E; Marucci G; Pardeo M; Insalaco A; Caiello I; Moneta GM; Prencipe G; De Benedetti F; Bracaglia C
    Pediatr Rheumatol Online J; 2019 May; 17(1):25. PubMed ID: 31118063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A MASsive attack: a pediatric case of macrophage activation syndrome complicated by DIC as an onset of systemic juvenile idiopathic arthritis successfully treated with anakinra and review of the literature.
    Maeser A; Biernacka-Zielinska M; Smolewska E
    Rheumatol Int; 2024 Mar; ():. PubMed ID: 38502236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Shimizu M; Mizuta M; Okamoto N; Yasumi T; Iwata N; Umebayashi H; Okura Y; Kinjo N; Kubota T; Nakagishi Y; Nishimura K; Mohri M; Yashiro M; Yasumura J; Wakiguchi H; Mori M
    Pediatr Rheumatol Online J; 2020 Jan; 18(1):2. PubMed ID: 31924225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
    Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
    Front Immunol; 2021; 12():750114. PubMed ID: 34691064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.